AJP - Lung Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (October 10, 2008). doi:10.1152/ajplung.90329.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/L1056    most recent
90329.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, E. P.
Right arrow Articles by Pearse, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, E. P.
Right arrow Articles by Pearse, D. B.
Submitted on May 31, 2008
Revised on October 7, 2008
Accepted on October 7, 2008

Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice

Eric P. Schmidt1, Mahendra Damarla1, Otgonchimeg Rentsendorj1, Laura E. Servinsky1, BING ZHU2, Aigul Moldobaeva1, Alfredo Gonzalez1, Paul M Hassoun1, and David B. Pearse1*

1 Johns Hopkins University
2 USACOM

* To whom correspondence should be addressed. E-mail: dpearse{at}jhmi.edu.

High tidal volume (HVT) ventilation causes pulmonary endothelial barrier dysfunction. HVT ventilation also increases lung nitric oxide (NO) and cGMP. NO contributes to HVT lung injury, but the role of cGMP is unknown. In the current study, ventilation of isolated C57BL/6 mouse lungs increased perfusate cGMP as a function of VT. Ventilation with 20 ml/kg VT for 80 min increased the filtration coefficient (Kf), an index of vascular permeability. The increased cGMP and Kf caused by HVT were attenuated by nitric oxide synthase (NOS) inhibition and in lungs from endothelial NOS (eNOS) knock-out mice. Inhibition of soluble guanylyl cyclase (sGC) in wild-type lungs (10 µM ODQ) also blocked cGMP generation and inhibited the increase in Kf, suggesting an injurious role for sGC-derived cGMP. sGC inhibition also attenuated lung Evans Blue dye albumin extravasation and wet/dry ratio in an anesthetized mouse model of HVT injury. Additional activation of sGC (1.5 µM BAY 41-2272) in isolated lungs at 40 min increased cGMP production and Kf in lungs ventilated with 15 ml/kg VT. HVT endothelial barrier dysfunction was attenuated with a nonspecific phosphodiesterase (PDE) inhibitor (100 µM IBMX) as well as an inhibitor (10 µM BAY 60-7550) specific for the cGMP-stimulated PDE2A. Concordantly, we found a VT-dependent increase in lung cAMP hydrolytic activity and PDE2A protein expression with a decrease in lung cAMP concentration that was blocked by BAY 60-7550. We conclude that HVT-induced endothelial barrier dysfunction resulted from a simultaneous increase in NO/sGC-derived cGMP and PDE2A expression causing decreased cAMP.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.